Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text
Navigating New Treatment Options for COPD | Consultant360
ICS, LAMA and LABA treatment after hospitalisation for severe COPD... | Download Scientific Diagram
Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
INCONTRI CON L'ESPERTO – BPCO:ICS, LAMA, LABA – Comitato Regionale Friuli Venezia Giulia
LAMA/LABA therapy reduced risk for COPD exacerbation, pneumonia hospitalization
effect of laBa/laMa versus laMa or laBa/ICs on safety outcomes | Download Table
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Page 14 - Rivista SIMG 1 - Maggio 2023 - web
Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane? | American Board of Family Medicine
American College of Chest Physicians - In a real-world setting, LAMA-LABA- ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook
Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
ICS/LABA/LAMA per la BPCO è stata approvata in Europa • NCF
Follow Up Treatment | Stiolto® Respimat® Inhalation Spray | HCP
Nuovi dati su ICS/LABA/LAMA vs LABA/LAMA per la BPCO • NCF
Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
LABA/LAMA vs ICS/LABA for exacerbations - Management of Stable COPD - GOLD COPD 2017 Resource Center: Activity Five
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine
Ellipta Inhalers We have 5 total inhalers that are ... | GrepMed
Pharmaceuticals | Free Full-Text | Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
Algorithm for withdrawal of ICS in symptomatic patients with COPD. a... | Download Scientific Diagram
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
A new alphabet for COPD care | European Respiratory Society
